South Korean drug manufacturer Firson was slapped with a warning letter and placed on an import alert by the FDA.

Roche has struck a deal to unload a plant in Spain to Recipharm, a move that will save 200 jobs as it sheds unneeded small-molecule facilities.

Japanese CDMO Ajinomoto Althea is expanding production at its recently completed high-potency products manufacturing facility in San Diego.

The vacant Novartis manufacturing facility in Suffern, New York, sold for $18 million to a buyer who then resold it to a developer for $30 million.

Pfizer is leaning heavily on Celltrion for biosimilar development and manufacturing, but its South Korean partner has stumbled with an FDA inspection.

Japan's Fujifilm Diosynth Biotechnologies has completed a $9 million expansion project of its cell manufacturing facilities in the U.K.

The FDA has sent its third warning letter in three months to facilities making homeopathic meds, raising concerns about potentially toxic ingredients.

Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility.